Optical Imaging for Monitoring Tumor Oxygenation Response after Initiation of Single-Agent Bevacizumab followed by Cytotoxic Chemotherapy in Breast Cancer Patients

• Shigeto Ueda ,

  * E-mail: syueda@saitama-med.ac.jp

  Affiliation Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan

  ⨯
• Ichiei Kuji,

  Affiliation Department of Nuclear Medicine, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan

  ⨯
• Takashi Shigekawa,

  Affiliation Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan

  ⨯
• Hideki Takeuchi,

  Affiliation Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan

  ⨯
• Hiroshi Sano,

  Affiliation Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan

  ⨯
• Eiko Hirokawa,

  Affiliation Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan

  ⨯
• Hiroko Shimada,

  Affiliation Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan

  ⨯
• Hiroaki Suzuki,

  Affiliation Central Research Laboratory, Hamamatsu Photonics K.K., Hamakita-ku, Hamamatsu, Japan

  ⨯
• Motoki Oda,

  Affiliation Central Research Laboratory, Hamamatsu Photonics K.K., Hamakita-ku, Hamamatsu, Japan

  ⨯
• Akihiko Osaki,

  Affiliation Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan

  ⨯
• Toshiaki Saeki

  Affiliation Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan

  ⨯